04:23 PM EDT, 04/08/2024 (MT Newswires) -- IBEX Technologies ( IBXNF ) on Monday said it completed the C$37.9 million sale of the company to a unit of BBI Solutions OEM Limited (BBI).

BBI acquired all of the issued and outstanding shares of IBEX at a price of $1.45 per share in cash.

The sale was approved by IBEX shareholders at an April 3 meeting, with a positive vote of approximately 99.83% of the shares voted.

In connection with the sale, IBEX has applied for delisting from the TSX Venture Exchange, which is expected to occur on or about Thursday, April 11, 2024.

IBEX manufactures and markets proteins for biomedical use through its subsidiary IBEX Pharmaceuticals Inc., in Montreal, Que.